Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
Wenshuai Li(Macau University of Science and Technology), Na Li(Suizhou Central Hospital), Shaocong Mo(Fudan University), Menglin Shi(PLA Rocket Force University of Engineering), Haoshu Cui(Fudan University), Jian‐Lin Wu(Macau University of Science and Technology), Jie Liu(Huashan Hospital), Xuanxuan Pan(Fudan University), Lirong Chen(Fudan University), Yida Pan(Fudan University), Yuru Shen(Fudan University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine)
Cited by 40
Related Papers
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183
Chinese Consensus Report on Family-Based<i>Helicobacter pylori</i>Infection Control and Management (2021 Edition)
|Gut|2021|183
Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe<i>in situ</i>perfusion culture of 3D hepatic spheroids
|Lab on a Chip|2018|162
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia
|Cancer Immunology Research|2018|137